Source: ERJ Open Res, 7 (4) 00396-2021; 10.1183/23120541.00396-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Jacques Boutros, Jonathan Benzaquen, Charles Hugo Marquette, Marius Ilié, Mickelina Labaky, Didier Benchetrit, Thibaut Lavrut, Sylvie Leroy, Richard Chemla, Michel Carles, Virginie Tanga, Charlotte Maniel, Olivier Bordone, Maryline Allégra, Virginie Lespinet, Julien Fayada, Jennifer Griffonnet, Véronique Hofman, Paul Hofman. Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing. ERJ Open Res, 7 (4) 00396-2021; 10.1183/23120541.00396-2021

Member's Comments

No comment yet.

Related content which might interest you: Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy Source: Eur Respir J, 58 (6) 2102099; 10.1183/13993003.02099-2021 Year: 2021 Comparative study of RSV detection by two collect methodologies: nasopharyngeal aspirate and oropharyngeal rubbing Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 Limitations of sweat conductivity determinations with Nanoduct analyzing system for rapid sweat testing in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Rapid detection of Mycobacterium tuberculosis from clinical specimens using a new target Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012 An Investigation into the ability of people with lung disease to provide breath specimens using a roadside screening device and an evidential breath testing device. Source: International Congress 2017 – Lung function testing Year: 2017 Evaluation of the detection of non-cultivable mycobacterium tuberculosis in human clinical samples Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Utility of BAL Galactomannan testing: A prospective analytical study Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Applicability of a parallel sampling device to evaluate and validate allergen assessment protocols Source: Eur Respir J 2004; 24: Suppl. 48, 451s Year: 2004 Accuracy of the multidisciplinary diagnosis of COVID-19 in patients with negative nasopharyngeal swabs RT-PCR, evaluated using BAL as diagnostic gold standard. Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy Year: 2021 Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Evaluation of patient adherence to tuberculosis treatment by measuring drug metabolites in urine Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004 Evaluation of AMD test for detection of M.Tuberculosis in respiratory specimens Source: Eur Respir J 2003; 22: Suppl. 45, 156s Year: 2003 The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies Source: Guideline 1997 Year: 1997 Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab Source: Eur Respir J, 57 (5) 2004430; 10.1183/13993003.04430-2020 Year: 2021 Applications of clinical exercise testing: different formats, different prognostic outcomes Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases Year: 2013 Applications of clinical exercise testing: different formats, different prognostic outcomes Source: International Congress 2014 – PG07 Cardiopulmonary exercise testing Year: 2014 Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017